🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Bio-tech startup Utopia Therapeutics raises $1.5 Mn led by Whale Tank

EntrackrEntrackr · 8m ago
Bio-tech startup Utopia Therapeutics raises $1.5 Mn led by Whale Tank
Medial

Utopia Therapeutics, a biotech company developing next-generation vaccines for chronic metabolic diseases, has secured $1.5 million in seed funding from Whale Tank. The proceeds will be utilized to accelerate the preclinical development of UT009, its lead immunotherapeutic candidate targeting obesity and support the advancement of UT009 toward regulatory toxicology studies, IND-enabling milestones, and Phase I human clinical trials, Utopia Therapeutics said in a press release. Co-founded in 2024 by Uday Saxena and Gopi Kadiyala, Utopia Therapeutics focuses on developing next-generation vaccines for chronic metabolic diseases, particularly obesity. The startup aims to deliver first-in-class vaccines for obesity and related metabolic diseases using novel scientific approaches. “Obesity is a global epidemic with limited long-term therapeutic options. UT009 represents a paradigm shift by differentiating it from current obesity drugs by addressing the root causes of weight gain. This investment enables us to move swiftly toward clinical translation,” said Uday Saxena and Gopi Kadiyala, co-founders of Utopia Therapeutics. According to the Hyderabad-based company, UT009 is a novel vaccine designed to reduce fat accumulation and improve metabolic health by targeting lipid-associated antigens. The company plans to scale up and commercialize Utopia’s UT018-based regenerative product line, built on GRAS-qualified, non-pharmaceutical applications.

1

Related News

Dronetech startup Zuppa raises $1.5 Mn in bridge round

EntrackrEntrackr · 7m ago
Dronetech startup Zuppa raises $1.5 Mn in bridge round
Medial

Dronetech startup Zuppa raises $1.5 Mn in bridge round Zuppa, a Chennai-based deep-tech startup focused on autonomous drone systems, has raised $1.5 million in a bridge funding round led by entrepreneur Rahul Dewan (founder of Srijan Technologies) with participation from Ajay Gupta (Capital Foods) and the Mangwani Family Office (ex-Aquapharm Chemicals). The round brings both capital and high-impact entrepreneurial backing to the company. The new funds will be used to strengthen Zuppa’s R&D and deepen its presence in defence and dual-use drone technologies. Founded by aerospace engineers, Zuppa builds fully indigenous drone intelligence platforms including flight control systems, vision guidance, secure cyber-physical stacks, and AI-based targeting. These systems are designed to operate independently of GPS and high-bandwidth internet, enabling performance in complex and remote environments. The firm claims to have built a high-barrier entry position in the defence drone segment and is already involved in post-Operation Sindoor deployments where Indian drone tech was found lacking. With deployments already underway and a patent-backed IP stack, Zuppa is also collaborating with academic institutions and government bodies to influence national drone policy and standards.

Avammune Therapeutics raises $12 Mn in Series A round

EntrackrEntrackr · 9m ago
Avammune Therapeutics raises $12 Mn in Series A round
Medial

Avammune Therapeutics and its subsidiary, Avammune Lifesciences, have secured $12 million in a Series A financing round co-led by Capital 2B, Shastra VC, and Kotak Lifesciences Fund I. The proceeds will be utilized to accelerate its proprietary pipeline, which targets the innate immune system, to develop orally bioavailable small molecules and support the clinical development of lead candidate AVA-NP-695 (an ENPP1 inhibitor). Co-founded in 2020 by Arun B. Papaiah, Srinivasan Namala, and Aditya Kulkarni, Avammune Therapeutics is a biopharmaceutical company discovering small molecule medicines that target the innate immune system for the treatment of cancer and autoimmune disorders. Its pipeline targets Osteosarcoma, Ewing’s Sarcoma, Triple-Negative Breast Cancer, GI cancers, and autoimmune disorders.

Alternative dairy startup 1.5 Degree raises $1 Mn in pre-Series A led by 35North Ventures

EntrackrEntrackr · 17d ago
Alternative dairy startup 1.5 Degree raises $1 Mn in pre-Series A led by 35North Ventures
Medial

Alternative dairy startup 1.5 Degree has raised $1 million in a pre-Series A round led by 35North Ventures’ India Discovery Fund II. The funding will be used to scale manufacturing, expand institutional partnerships, and enter new cities including Mumbai, Pune, Bengaluru, Hyderabad, and Delhi. Operated by Natturz Bio Kontrol Pvt Ltd, 1.5 Degree focuses on the institutional food service market, supplying plant-based dairy and frozen dessert products to corporate cafeterias, hotels, educational institutions, and large dining operations. The firm partners with food service providers such as Compass Group and Sodexo. Its product portfolio includes plant-based milk, yogurt, tofu, cooking cream, gelatos, frozen desserts, smoothie yogurt bowls, and oat-milk-based beverages. The company also operates in-institution QSR formats and supplies products through long-term B2B contracts. 1.5 Degree uses proprietary processing technology to address taste and flavor challenges commonly associated with plant-based dairy products tailored for Indian consumers. The company claims its products result in significantly lower emissions and water usage compared to traditional dairy. The brand derives nearly 80% of its revenue from institutional contracts, offering predictable and recurring revenue through volume-based agreements and integrated supply chain operations. It is currently operational across Bengaluru, Pune, and NCR. While remaining B2B-focused, 1.5 Degree has also started expanding into direct-to-consumer channels through premium retail outlets, experience centers, and cloud kitchens via food delivery platforms.

Bio-tech startup PeelON raises $1 Mn in seed round led by growX Ventures

EntrackrEntrackr · 6m ago
Bio-tech startup PeelON raises $1 Mn in seed round led by growX Ventures
Medial

Bio-tech startup PeelON raises $1 Mn in seed round led by growX Ventures PeelON, a bio-tech startup specialising in biodegradable, compostable packaging for fresh produce, has raised $1 million in a seed funding round led by deep-tech-focused VC firm growX Ventures along with participation from Boston Venture Group, Clean Energy Venture Group, and Climate Angels. The proceeds will be deployed to expand R&D and production facilities in Visakhapatnam, hire across sales (USA and India), R&D, and regulatory compliance, and launch marketing campaigns, PeelON said in a press release. Co-founded in 2020 by Taraka Ramji Moturu and Venkata Ravi Sankar Ummidi, PeelON develops plant-based films that extend the shelf life of fruits and vegetables by up to 3x. It operates on a B2B model, working with farmers, exporters, and retailers to eliminate single-use plastics at every stage of the fresh produce supply chain. According to PeelON, it offers two flagship products, engineered to address the respective pain points of bulk shipments and retail products. While its first product PeelON-Fresh offers liners for bulk shipments, its second product PeelON-Retail+ offers retail-ready bags with natural antimicrobial agents and ethylene scavengers to maintain freshness and reduce food spoilage. PeelON’s solutions are being commercially deployed across crops such as cilantro, broccoli, leafy greens, rambutan, and banana, with clients in Maharashtra and Andhra Pradesh in India, as well as in Texas, Florida, and California in the US. The company also has active collaborations with universities and compostable materials labs in the USA and India to expand its solutions to other items. The company plans to expand production capacity in India and the US, become the go-to packaging solution for sustainable exporters in India, Mexico, and Southeast Asia, and launch retail compostable packaging formats in the US and Canadian markets. It also aims to pilot a blockchain-enabled traceability platform for carbon and shelf-life validation.

Download the medial app to read full posts, comements and news.